However, Hessman et al. [48] demonstrated that ALDH1 is expressed in non-metastatic CRC, thereby suggesting its role and potential involvement as a druggable target only in early phase of cancer progression. The gene discussed is ALDH1A1; the disease is colorectal carcinoma.